Klinikum St. Georg gGmbH

At Klinikum St. Georg gGmbH in Leipzig, clinical research in immune system diseases and kidney disorders focuses on IgA nephropathy and primary membranous nephropathy. These studies are designed to test new treatments that may reduce proteinuria, protect kidney function, and improve outcomes for people living with chronic autoimmune-related renal disease.

• Testing a new therapy for IgA nephropathy and related renal inflammation
• Evaluating treatment effectiveness in primary membranous nephropathy
• Measuring whether therapy can preserve kidney function and reduce protein loss

This area reflects a strong interest in better long-term care for patients with progressive glomerular diseases.

Research in bacterial infections and intensive care at this site includes studies on Staphylococcus aureus bacteremia and treatment approaches for seriously ill patients. The goal is to improve survival, support recovery, and identify the most effective strategies for managing severe bloodstream infections in hospital settings.

• Assessing interventions for Staphylococcus aureus bacteremia
• Studying ways to lower mortality in critically ill patients
• Improving treatment effectiveness for severe bacterial infections

These trials connect infectious disease research with the practical challenges of intensive care medicine.

Clinical trials in digestive system diseases include work on liver cirrhosis with features of portal hypertension. The research aims to evaluate new combination therapies that may reduce pressure in the portal circulation and improve the management of advanced liver disease.

• Studying liver cirrhosis with portal hypertension
• Testing whether treatment can lower portal pressure
• Exploring better options for advanced liver disease

This line of research addresses serious complications of chronic hepatic disease that can strongly affect quality of life.

The oncology portfolio at Klinikum St. Georg gGmbH covers both neoplasms and personalized cancer treatment. Studies include HR+/HER2- early breast cancer, locally advanced or metastatic breast cancer, colon cancer, and rectal cancer. The main purpose is to improve survival, refine adjuvant treatment choices, and support organ-preserving approaches where possible.

• Testing new approaches for hormone receptor-positive breast cancer
• Comparing treatment strategies for colon cancer and rectal cancer
• Evaluating whether therapy can improve disease-free survival and organ preservation

These studies reflect a broad effort in cancer research to balance effectiveness with better long-term outcomes for patients.

Research in digestive system diseases also includes studies of ulcerative colitis and recovery after gastrectomy. The focus is on improving symptom control, quality of life, and supportive care after major gastrointestinal surgery, while also evaluating medicines for inflammatory bowel disease in younger patients.

• Assessing treatment for ulcerative colitis in pediatric patients
• Studying digestive support after gastrectomy
• Improving quality of life and disease control in gastrointestinal disorders

These trials combine inflammatory bowel disease research with practical recovery-focused care.

The site also participates in research on hilar cholangiocarcinoma and advanced rectal cancer, where treatment decisions can be especially complex. The purpose of these trials is to compare local and systemic treatment options, improve survival, and support less invasive approaches when appropriate.

• Studying treatment options for hilar cholangiocarcinoma
• Evaluating approaches for intermediate and high-risk rectal cancer
• Exploring ways to improve survival while reducing the need for major surgery

This research area highlights the hospital’s involvement in challenging gastrointestinal oncology cases.

Trials in immune system diseases and phenomena and processes include studies of human normal immunoglobulin and primary immunodeficiency diseases. The research aims to confirm whether newer immunoglobulin treatment approaches can help prevent serious infections while maintaining adequate immune protection.

• Evaluating immunoglobulin therapy for patients with immune deficiency
• Testing protection against serious bacterial infections
• Assessing whether treatment can maintain stable IgG levels

These studies support better long-term management of immune deficiency and infection risk.

Clinical research in musculoskeletal diseases includes polyarticular-course juvenile idiopathic arthritis, with a focus on safety, tolerability, and symptom control in children and adolescents. The aim is to improve disease management in a young population affected by chronic joint inflammation.

• Studying treatment for juvenile idiopathic arthritis
• Evaluating safety and effectiveness in pediatric rheumatology
• Supporting better control of inflammatory joint disease

This work strengthens the site’s role in childhood inflammatory disease research.

Within intensive care and disorders of environmental origin, the site is involved in studies of severe burn injury. These trials aim to improve recovery after life-threatening burns by testing whether supportive treatment can reduce organ dysfunction and lower the risk of death.

• Studying treatment for severely burned patients
• Evaluating ways to reduce organ dysfunction after major injury
• Improving survival in acute burn care

This research addresses urgent needs in critical care medicine and trauma-related recovery.